BP
OGN icon

Ballentine Partners’s Organon & Co OGN Stock Holding History

Ballentine Partners’s Portfolio OGN Stock Details OGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-11,912
Closed -$85.4K – 1071
2025
Q4 		$85.4K Sell
11,912
-812
-6% -$6.42K ﹤0.01% 975
2025
Q3 		$136K Buy
12,724
+2,496
+24% +$24.5K ﹤0.01% 959
2025
Q2 		$99K Sell
10,228
-10,707
-51% -$110K ﹤0.01% 940
2025
Q1 		$312K Buy
20,935
+3,780
+22% +$58.1K 0.01% 610
2024
Q4 		$256K Sell
17,155
-2,150
-11% -$35K ﹤0.01% 666
2024
Q3 		$369K Buy
19,305
+200
+1% +$4.14K 0.01% 514
2024
Q2 		$395K Buy
19,105
+552
+3% +$11K 0.01% 465
2024
Q1 		$349K Buy
18,553
+1,969
+12% +$33.8K 0.01% 494
2023
Q4 		$239K Buy
+16,584
New +$226K ﹤0.01% 578

Other funds holding OGN

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $55.1B AUM 45.38% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
KBG
Kahn Brothers Group New York $633M AUM 39.01% 1-Year Est. Return
Canada Pension Plan Investment Board
Canada Pension Plan Investment Board Toronto Ontario, Ontario, Canada $181B AUM 41.77% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
PMG
Private Management Group Irvine, California $3.8B AUM 23.19% 1-Year Est. Return

Ballentine Partners's OGN Position: Q1 2026 in Review

Ballentine Partners sold out of Organon & Co (OGN) in Q1 2026, closing a stake of 11,912 shares — an estimated $85.4K sold.

Ballentine Partners first reported a position in OGN in Q4 2023 and held it in 9 quarters. The position peaked at $395K in Q2 2024. 608 funds tracked by Wall St. Rank hold OGN as of Q1 2026.

  • Ballentine Partners reported no remaining Organon & Co position as of Q1 2026 after selling out during the quarter.
  • Ballentine Partners sold 11,912 Organon & Co shares in Q1 2026, an estimated $85.4K.
  • Ballentine Partners first reported a position in Organon & Co in Q4 2023 and held it in 9 quarters.
  • Ballentine Partners's Organon & Co position peaked at $395K in Q2 2024.
  • 608 funds tracked by Wall St. Rank held Organon & Co as of Q1 2026.

Based on Ballentine Partners's 13F filing for Q1 2026, filed 14 May 2026.